Extended Partnership Agreement Will Expand Availability Across Europe of Gencurix’ In Vitro Diagnostic (IVD) Assays Using ...

Tire Building Machine Market is witnessing significant evolution driven by advancements in tire manufacturing technology, increasing demand for high-performance tires, and the need for more ...

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, and Gencurix, Inc., a ...

The partnership includes commercialization, joint marketing, and product development for Gencurix's Droplex precision medicine testing.

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced today that the company’s ...

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) ...

Qiagen N.V. (NYSE:QGEN) ranks among the best CRISPR stocks to buy. Qiagen N.V. (NYSE:QGEN) and Gencurix announced a collaboration on June 18 to provide oncology assays for Qiagen’s QIAcuityDx digital ...

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and GENCURIX, Inc. (KOSDAQ: 229000) today announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a ...

* Transcription-mediated amplification (TMA) tests and commercially available reverse transcription polymerase chain reaction (RT-PCR) tests specifically designed to omit/adapt RNA ...

Tracer Biotechnologies Friday reported a strategic partnership with QIAGEN (NYSE:QGEN) to co-develop and commercialize minimal residual disease (MRD) assays for solid tumors on QIAGEN’s QIAcuity ...